ARCHIVES

Afinitor Tablet Doubles PFS; Lowers Progression Risk 65%

This article is from The Cancer Letter archive.

Vol. 34 No. 2 | February 25, 2011

Download PDF Visit The Full Archive

Related Articles

High-Dose Chemo, Stem Cell Transplant No Benefit For Node+ Breast Cancer

January 25, 2008

DCCR Gets Go Ahead For New Community Clinical Oncology Program, $600,000 – $1 Million a Year

May 12, 1978

NCCS Networker Volume 9 Issue 2, Summer 1995

June 13, 1995

CCOP Reponses So Far Indicates application To Total 150-200

August 27, 1982

NCI Intends To Extend OSCC Two More Years

October 3, 1986

Hammer Goes Public With Appeal for Increased Funding

March 14, 1986